FPR2 and Cachexia: In the absence of Fpr2/3, 17R-RvD1 no longer attenuated the clinical score (Figure 6F), the swelling of hind paws, or the arthritis-related manifestation of cachexia, and disease penetrance was almost identical between the 2 genotypes (data not shown).